Antisense, RNA
Antisense, RNA Companies (4)
Antisense, RNA News
-
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Delivering on mRNA-based therapeutics: innovations in applications and packaging
Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet... -
News A United Cause: strategic partnership between BioNTech and the Government of the UK announced
A multi-year collaboration between BioNTech and the Government of the United Kingdom will see the expansion of the company’s presence in the UK, focusing on areas like cancer immunotherapies and infectious disease vaccines.
Antisense, RNA Products (12)
-
Product CordenPharma Lipid Data Sheet > C12-200
• Chemical name: 1,1‘-((2-(4-(2-((2-(bis(2-hydroxydodecyl)amino)ethyl)(2-hydroxydodecyl)amino)ethyl)piperazin-1-yl)ethyl)azanediyl)bis(dodecan-2-ol) Application: Lipid NanoParticles as delivery systems for enabling the therapeutic potential of siRNA, mRNA or CRISPR as they exhibit remarkable in ... -
Product Oligonucleotide Analytical Development Services
Analytical development services for oligonucleotides: For oligo-based drugs, our capabilities range from GLP bioanalysis to GLP/cGMP characterisation. We support product development, from quality control testing of amidite starting materials and early stage product characterization through to GMP batch r... -
Product 1 GHz NMR
New Evo 1 GHz NMR fits in 1 story building, uses 70% less helium. Ideally suited to characterise complex molecules such as RNA, oligonucleotides, peptides, antibodies and more! -
Product Oligonucleotides
Sumitomo Chemical has unique manufacturing technology for long (more than 100-mer) oligonucleotides with purity of 90% -
Product Large Molecule Discovery & Development Services
We provide a wide range of discovery and development services for New Biological Entities (NBEs) from our state-of-the-art facility located in Hyderabad, India. At the core of NBE services is a talented team of scientists experienced in the design and delivery of a range of advanced therapeutic modalities ... -
Product Oligonucleotide Process Development and Manufacturing
WuXi STA has an integrated Oligo API process R&D and manufacturing platform from preclinical to commercial, operating at our US FDA inspected integrated process R&D and manufacturing facility based in Changzhou, China. We support the development and manufacture of a variety of oligonucleotide modal... -
Product CordenPharma BotaniChol® Plant-Based Cholesterol
Chemists at CordenPharma and the Otto-von-Guericke-University of Magdeburg, Germany developed a scalable synthesis of pharma-grade cholesterol based on botanical sources. This offers a large-scale production of highly needed cholesterol, which is used as part of the lipid cocktail ... -
Product mRNA Characterisation and Analysis
Characterization and analysis of mRNA supporting vaccine and therapeutic development, including assessing clinical translation efficiency and immunogenicity. At our GLP / GCP / GMP laboratories, scientists can test a mRNA drug substance or drug product to help you confidently assess batch to batch manufa... -
Product Bespoke Oligonucleotide Synthesis Service and Partnerships
Whether you need a single sequence for a project or are looking for a long-term collaborative partner, we synthesize and deliver the best DNA/RNA oligonucleotides for your precise needs. Oligonucleotides are the backbone of molecular diagnostics and the future of personalised medicine. We synthesize and d... -
Product Generic / Monomer
1. Generic ST Pharm focusing on technical challenging and brand generics. We specialize in MRI contrast agents and and possess a portfolio of tuberculosis and anti-infectious drugs as generic APIs. 2. Monomer ST Pharm offers a one-stop service from nucleosides to phosphoramidites with specialty and commo... -
Product Oligo Synthesis
• Unlabeled oligos • Custom DNA oligos • Custom RNA oligos • qPCR primer and Probe • siRNA, sgRNA, crRNA, ASO etc. -
Product ATB-301
[TGF-β2 Targeting ASO (TASO) + IL-2 Combination therapy] - Phase Ib
1. Confirm the potential of TGF-β2 as a biomarker in human blood and tumor tissues from the efficacy result of Phase Ib clinical trial on cancer patients
2. Confirm the suppression of IL-2’s side effect in combinati...
Upcoming Events
-
CPHI & PMEC China 2024
Shanghai New International Expo Center
19 - 21 June 2024 -
CPHI South East Asia 2024
Queen Sirikit National Convention Center, Bangkok, Thailand
10 Jul 2024 - 12 Jul 2024 -
CPHI Korea 2024
COEX, Seoul, Korea
27 - 29 August 2024
Pharmaceutical Industry Webinars
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance